Abbvie stock price target raised to $258 from $240 at BMO Capital
PositiveFinancial Markets

Abbvie's stock price target has been raised to $258 from $240 by BMO Capital, reflecting growing confidence in the company's future performance. This adjustment is significant as it indicates analysts' optimism about Abbvie's potential for growth and profitability, which could attract more investors and positively impact the stock market.
— Curated by the World Pulse Now AI Editorial System